# A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease

> **NCT07254806** · PHASE3 · RECRUITING · sponsor: **DiscGenics, Inc.** · enrollment: 162 (estimated)

## Conditions studied

- Degenerative Disc Disease

## Interventions

- **BIOLOGICAL:** IDCT (rebonuputemcel)
- **OTHER:** Sham (No Treatment)

## Key facts

- **NCT ID:** NCT07254806
- **Lead sponsor:** DiscGenics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-23
- **Primary completion:** 2027-11-24
- **Final completion:** 2028-11-24
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07254806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07254806, "A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07254806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*